Literature DB >> 21647706

Blockade of P2 nucleotide receptors after spinal cord injury reduced the gliotic response and spared tissue.

Ana E Rodríguez-Zayas1, Aranza I Torrado, Odrick R Rosas, José M Santiago, Johnny D Figueroa, Jorge D Miranda.   

Abstract

Spinal cord injury (SCI) triggers a sequel of events commonly associated with cell death and dysfunction of glias and neurons surrounding the lesion. Although astrogliosis and glial scar formation have been involved in both damage and repair processes after SCI, their role remains controversial. Our goal was to investigate the effects of the P2 receptors antagonists, PPADS and suramin, in the establishment of the reactive gliosis and the formation of the glial scar. Molecular biology, immunohistochemistry, spared tissue, and locomotor behavioral studies were used to evaluate astrogliosis, in adult female Sprague-Dawley rats treated with P2 antagonists after moderate injury with the NYU impactor device. Semi-quantitative RT-PCR confirmed the presence of P2Y(1,) P2Y(2,) P2Y(4,) P2Y(6,) P2Y(12), and P2X(2) receptors in the adult spinal cord. Immunohistochemistry studies confirmed a significant decrease in GFAP-labeled cells at the injury epicenter as well as a decrease in spared tissue after treatment with the antagonists. Functional open field testing revealed no significant locomotor score differences between treated and control animals. Our work is consistent with studies suggesting that astrogliosis is an important event after SCI that limits tissue damage and lesion spreading.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21647706      PMCID: PMC3522077          DOI: 10.1007/s12031-011-9567-6

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  77 in total

1.  Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A.

Authors:  D Merkler; G A Metz; O Raineteau; V Dietz; M E Schwab; K Fouad
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

2.  P2X7 receptor inhibition improves recovery after spinal cord injury.

Authors:  Xiaohai Wang; Gregory Arcuino; Takahiro Takano; Jane Lin; Wei Guo Peng; Pinglan Wan; Pingjia Li; Qiwu Xu; Qing Song Liu; Steven A Goldman; Maiken Nedergaard
Journal:  Nat Med       Date:  2004-07-18       Impact factor: 53.440

Review 3.  Nucleotide signaling in nervous system development.

Authors:  Herbert Zimmermann
Journal:  Pflugers Arch       Date:  2006-04-25       Impact factor: 3.657

Review 4.  Glial cell extracellular matrix: boundaries for axon growth in development and regeneration.

Authors:  M T Fitch; J Silver
Journal:  Cell Tissue Res       Date:  1997-11       Impact factor: 5.249

5.  Upregulation of EphA3 receptor after spinal cord injury.

Authors:  Margarita Irizarry-Ramírez; Christopher A Willson; Lillian Cruz-Orengo; Johnny Figueroa; Ixane Velázquez; Hope Jones; Roy D Foster; Scott R Whittemore; Jorge D Miranda
Journal:  J Neurotrauma       Date:  2005-08       Impact factor: 5.269

Review 6.  P2 receptors and neuronal injury.

Authors:  Heike Franke; Ute Krügel; Peter Illes
Journal:  Pflugers Arch       Date:  2006-04-28       Impact factor: 3.657

7.  Dural repair reduces connective tissue scar invasion and cystic cavity formation after acute spinal cord laceration injury in adult rats.

Authors:  Christopher Iannotti; Y Ping Zhang; Lisa B E Shields; Yingchun Han; Darlene A Burke; Xiao-Ming Xu; Christopher B Shields
Journal:  J Neurotrauma       Date:  2006-06       Impact factor: 5.269

8.  Essential protective roles of reactive astrocytes in traumatic brain injury.

Authors:  D J Myer; G G Gurkoff; S M Lee; D A Hovda; M V Sofroniew
Journal:  Brain       Date:  2006-07-05       Impact factor: 13.501

Review 9.  Regulation of glial fibrillary acidic protein (GFAP) expression in CNS development and in pathological states.

Authors:  F C Chiu; J E Goldman
Journal:  J Neuroimmunol       Date:  1985-06       Impact factor: 3.478

10.  Molecular, anatomical, physiological, and behavioral studies of rats treated with buprenorphine after spinal cord injury.

Authors:  José M Santiago; Odrick Rosas; Aranza I Torrado; María M González; Priya O Kalyan-Masih; Jorge D Miranda
Journal:  J Neurotrauma       Date:  2009-10       Impact factor: 5.269

View more
  6 in total

1.  Antagonism of purinergic signalling improves recovery from traumatic brain injury.

Authors:  Anthony M Choo; William J Miller; Yung-Chia Chen; Philip Nibley; Tapan P Patel; Cezar Goletiani; Barclay Morrison; Melinda K Kutzing; Bonnie L Firestein; Jai-Yoon Sul; Philip G Haydon; David F Meaney
Journal:  Brain       Date:  2013-01-04       Impact factor: 13.501

2.  Diadenosine tetraphosphate (Ap4A) inhibits ATP-induced excitotoxicity: a neuroprotective strategy for traumatic spinal cord injury treatment.

Authors:  David Reigada; Rosa María Navarro-Ruiz; Marcos Javier Caballero-López; Ángela Del Águila; Teresa Muñoz-Galdeano; Rodrigo M Maza; Manuel Nieto-Díaz
Journal:  Purinergic Signal       Date:  2016-10-19       Impact factor: 3.765

3.  Purinergic Modulation of Spinal Neuroglial Maladaptive Plasticity Following Peripheral Nerve Injury.

Authors:  Giovanni Cirillo; Anna Maria Colangelo; Miluscia Berbenni; Vita Maria Ippolito; Ciro De Luca; Francesco Verdesca; Leonilde Savarese; Lilia Alberghina; Nicola Maggio; Michele Papa
Journal:  Mol Neurobiol       Date:  2014-10-29       Impact factor: 5.590

Review 4.  Purinergic signaling systems across comparative models of spinal cord injury.

Authors:  Eva E Stefanova; Angela L Scott
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

Review 5.  MicroRNA: Crucial modulator in purinergic signalling involved diseases.

Authors:  Jing Guo; Peng Yang; Yi-Fan Li; Jin-Fan Tang; Zhao-Xuan He; Shu-Guang Yu; Hai-Yan Yin
Journal:  Purinergic Signal       Date:  2022-02-02       Impact factor: 3.765

6.  P2Y2 Receptor Mediated Neuronal Regeneration and Angiogenesis to Affect Functional Recovery in Rats with Spinal Cord Injury.

Authors:  Ruidong Cheng; Genying Zhu; Chengtao Ni; Rui Wang; Peng Sun; Liang Tian; Li Zhang; Jie Zhang; Xiangming Ye; Benyan Luo
Journal:  Neural Plast       Date:  2022-02-02       Impact factor: 3.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.